Japan’s mobile sector accelerated again in Q4 and we think is heading to above inflation. With both KDDI and DCM recently announcing price increases the environment is increasingly benign and should be helped by NTT’s recent acquisition of SBI Sumishin Net Bank. Our recent trip to Japan highlighted how positive the environment is; NTT stays our preferred pick, with KDDI closely behind.
As has been widely rumoured, NTT has offered to acquire up to 66% of SBI Sumishin Bank (7163-JP), in a bid to strengthen its financial services offering. The offer price (¥3,615) represents a 10% premium to yesterday’s price, but actually around 10% below today’s closing price.
We met with all 3 of the incumbent Japanese Telcos & Rakuten in Tokyo last week, as well as visiting Osaka to talk to NTT in more depth about IOWN. Overall, we remain bullish on Japanese telcos operationally and buyers of all three incumbents. NTT remains our top pick followed by KDDI.
KDDI reported a better top-line, and generous shareholder remuneration. However, guidance is largely in line and leaves us wondering what happens after the company hits it in March ’26. Within this space, NTT remains our preferred pick on potential upside catalysts (IOWN revenue optionality, NTT Data and Fixed line rebound) while KDDI remains a close second with a ¥3,150 price target.
As rumoured, NTT has offered to buy out the minorities (~42.3%) of NTT Data via a tender offer, at a 34% premium, or ¥4,000 per share. This is a slightly lower premium than we would have expected and implies a transaction value for the minority stake of ¥2.4tn (USD 16.5bn). Quick thoughts below.
KDDI reported an improved bottom-line trend, supported by its steady topline and Lawson’s contribution. While mobile ARPU was marginally down in Q3, it was still growing sequentially, and the company anticipates mobile communication ARPU revenue to inflect back to growth in the next quarter on the back of continued up-trading and UQ to AU brand migration.
Tags: NTT Corp (9432 JT), Equinix (EQIX US), Iron Mountain (IRM US), Amazon (AMZN US), Microsoft (MSFT US), Google (GOOG US), Digital Realty Trust (DLR US), QTS (owned by Blackstone (BX US)), CyrusOne (owned by KKR (KKR US) and Global Infrastructure Partners (pvt), Cyxtera (owned by Brookfield Infrastructure Partners (BIP US)), Cologix (pvt), Meta (META US), Apple (AAPL US), Oracle (ORCL US), Netflix (NFLX US), Money Forward (3994 JT), Digital Realty Trust (DLR US), DataBridge Group (DBRG US), N...
After 3 good years, 2024 was not great for the Japanese incumbents; with KDDI and SoftBank rising modestly and NTT falling, but all underperforming the Nikkei. In our view, risk is rising in Mobile, although we continue to see the sector as fundamentally undervalued. Rakuten performed well in 2024, but this was really to do with balance sheet risk easing on the back of cost cutting/refinancing rather than better traction in Mobile.
Service revenue slowed for the incumbents but stayed in the low-single digit band, with Softbank still ahead followed by NTT. Mobile divergence continues to play out with SB leading the pack and is likely to remain so in our view. Industry EBITDA improved as NTT inflected to growth and led to a strong EBIT beat this quarter.
KDDI today announced an increase in their share buyback from ¥300-¥400bn this year. On the call, the company indicated that this pace could be maintained at least for next year suggesting a structural increase in share buybacks. Thoughts below.
KDDI’s results were okay in Q2 as it was pegged against a tougher comparable. Topline remained ahead of expectations while EBIT was slightly behind YTD though we believe it is likely to improve on the back of DX, synergies from Lawson, mobile and declining roaming losses from Rakuten
PLANO, Texas--(BUSINESS WIRE)-- , a global leader in healthcare IT, and Duke Health, a world-class academic and healthcare system, are collaborating to create a highly interactive and technologically advanced model for augmented home care delivery. This new home-care model will integrate multiple technologies, including a GenAI-driven virtual agent from Ellipsis Health, automation, device interoperability, remote patient monitoring and a patient app and portal. The solution will keep medical staff in direct contact with the patient to ensure a human is always in the loop while allowing patien...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.